Among the detected alternations, the eight-major driver mutations of lung cancer (EGFR, ALK, ERBB2, MET, RET, ROS1, BRAF, and KRAS) could be found in 14 out of 17 (82.4%) patients using both surgical and CNB specimens (Table 3). This evidence concerns the gene MET and lung cancer.